TLS Detect
Research-use AI test that screens digitised H&E slides for tertiary lymphoid structures, a biomarker associated with response to immune checkpoint inhibitors, across tumour types and without a separate stain.
Find alternatives to TLS Detect
What it does
- Medical imaging analysis
Features 3
- Pan-tumor TLS detectionDetects Tertiary Lymphoid Structures across tumor types from digitized H&E slides.
- PDF report with heat mapDelivers a PDF report including a dynamic heat map.
- TLS presence scoreNotes the presence or absence of TLS with score predictions.
Sources
- Pricing
-
Read in full 2026-09-19: no price, rate, plan or licence figure appears on the page, and waiv.com publishes no pricing page.
- Description
-
Official documentation · 19 Sep 2026
Read 2026-09-19: "Gain insights into a tumor's interaction with the immune system", "TLS provide crucial insights to better understand the response to immunotherapies", "Pan-tumor -- Suitable for tumor specimens across multiple indications", "Digital pathology -- Works with tumor tissue on digitized H&E slides", "97% Sensitivity", and "Intended users: Researchers in a non-clinical" setting.
- What it does
-
Official documentation · 19 Sep 2026
Reading digitised pathology slides to report a biomarker is medical-imaging-analysis. No other capability is claimed on the page.
- Sold within
-
Waiv's page offers only "Request a Demo" and a case study, and the site publishes no pricing or packaging page, so the purchasing route could not be established; the
accesskey is left absent rather than defaulted. No parent offering is named on the page either -- unlike Waiv's three clinical tests, which are delivered through the Destra platform. - Name
-
Official documentation · 19 Sep 2026
Waiv's own precision-testing catalogue links it as "TLS Detect"; the page names it in its own prose, "With a sensitivity of 97%, TLS Detect supports the screening for TLS presence across tumors within a research setting".
- URL
-
Official documentation · 19 Sep 2026
The product's own page, found in the link graph of waiv.com/precision-testing/products and read in full on 2026-09-19.
- Deployment
-
Official documentation · 19 Sep 2026
Delivered as a hosted analysis over digitised whole-slide images, the same way Waiv describes its other tests; no on-premises or device edition is offered on the page.
Also from Waiv
-
BRCAura RUO Data service
Research-use-only AI test assessing BRCA-related genomic risk signatures from pathology data, sold to research institutions rather than clinical end users.
-
Destra Platform
Workflow platform that orchestrates Waiv's diagnostic tests within a lab's existing pathology workflow, handling sample intake, result delivery and reporting.
-
MSIntuit Suite Data service
Suite of AI diagnostic tests covering colorectal, endometrial and gastric cancer screening from pathology slides, marketed as one branded product line on Waiv's own site.
-
RlapsRisk BC Data service
CE-IVDR-cleared AI diagnostic test that predicts breast-cancer recurrence risk from routine pathology data, spun out of Owkin's diagnostics division.
Something wrong here? Send a correction — quote this product id: waiv-tls-detect.